tyrosine and Bronze Diabetes

tyrosine has been researched along with Bronze Diabetes in 57 studies

Research

Studies (57)

Timeframe	Studies, this research(%)	All Research%
pre-1990	2 (3.51)	18.7374
1990's	24 (42.11)	18.2507
2000's	26 (45.61)	29.6817
2010's	4 (7.02)	24.3611
2020's	1 (1.75)	2.80

Authors

Authors	Studies
Borgaonkar, M; Lim, DR; Phua, C; Vidyasankar, G	1
Bratkovic, D; Couper, R; Davidson, GP; Fahy, R; Fletcher, JM; Mackay, RJ; Ranieri, E	1
Lawless, MW	1
Brehm, A; Spínola, C; Spínola, H	1
de Groot, RH; de Kort, WL; Durga, J; Jolles, J; Kok, FJ; Schiepers, OJ; Swinkels, DW; van Boxtel, MP; Verhoef, P	1
Bugianesi, E; Carrozzo, M; Chiusa, L; Conrotto, D	1
Jacobs, EM; Swinkels, DW	1
Ascaso, C; Bruguera, M; Ingelmo, M; Oliva, R; Sánchez, M; Sanz, C; Villa, M	1
Bassett, ML; Cadet, E; Carter, K; David, V; Jouanolle, AM; Livesey, KJ; Merryweather-Clarke, AT; Mosser, A; Pointon, JJ; Poulton, J; Roberts, AG; Robson, KJ; Rochette, J; Wimhurst, VL; Worwood, M	1
Fenger, K; Melsen, GV; Milman, N; Ovesen, L; Pedersen, P	1
Anderson, GJ; Powell, LW; Ramm, GA; Subramaniam, VN	1
Fleming, RE; Gui, D; Kawabata, H; Koeffler, HP; Moon, SY; O'Kelly, J; Said, JW; Saitoh, T; Umehara, Y; Wano, Y	1
Biesiada, G; Dropiński, J; Dziedzina, S; Mach, T; Sanak, M; Szczeklik, W; Szułdrzyński, K	1
Dávid, K; Horváth, G	1
Chanu, B; Férec, C; Ka, C; Le Gac, G; Mercier, AY; Mérour, MC; Mura, C; Nousbaum, JB; Scotet, V	1
Brajenović-Milić, B; Jazbec, SS; Kapović, M; Lovrecić, L; Peterlin, B; Ristić, S; Sepcić, J; Starcević-Cizmarević, N	1
Meier, P; Schuff-Werner, P; Steiner, M	1
Whittington, C	1
Distante, S	1
Abraham, SC; Adams, LA; Angulo, P; Brandhagen, D; Torgerson, H	1
Baldacci, F; Chiti, A; Gallerini, S; Morelli, N; Murri, L; Orlandi, G; Sonnoli, C	1
Hansson, N; Olsson, KS; Ritter, B	1
Lawless, MW; Mankan, AK; Norris, S; Ryan, AW	1
Adhoute, X; Castéra, L; Chanteloup, E; Couzigou, P; de Lédinghen, V; Foucher, J; Laharie, D; Lovato, B; Merrouche, W; Terrebonne, E; Vergniol, J	1
Rabinowitz, JG	1
Kohgo, Y; Ono, M	1
Camaschella, C; Carella, M; D'Ambrosio, L; Franco, B; Gasparini, P; Girelli, D; Grifa, A; Piperno, A; Roetto, A; Totaro, A; Valentino, MA	1
Chang, JG; Lin, SF; Liu, TC	1
Acton, RT; Barton, JC; Harmon, L; Rivers, C; Rothenberg, BE; Sawada-Hirai, R; Shih, WW	1
Cox, TM; Raha-Chowdhury, R; Rhodes, DA; Trowsdale, J	1
Aslam, S; Standen, GR	1
Burt, MJ; Chapman, BA; Faed, JM; George, PM; Morison, IM; Upton, JD	1
Bevan, D; Jeffery, S; Killick, S; Otter, M; Rist, C	1
Smillie, D	1
Gottschalk, R; Hoelzer, D; Kaltwasser, JP; Löffler, T; Seidl, C; Seifried, E	1
Airaud, F; Andre, MT; Benichou, B; Herbert, O; Jacquemont, S; Moisan, JP; Raguenes, O; Renault, S	1
Ellard, S; Frayling, T; Grove, J; Hattersley, AT; Walker, M	1
Bach, JF; Boitard, C; Caillat-Zucman, S; Djilali-Saiah, I; Dubois-Laforgue, D; Larger, E; Mercadier, A; Timsit, J	1
Baiget, M; Barceló, MJ; Gimferrer, E	1
Jouanolle, AM; Pinson, S; Plauchu, H; Turlin, B; Yaouanq, J	1
Lucotte, G	1
Callender, ME; Curran, MD; McDougall, N; Middleton, D; Murphy, S; O'Brien, CJ	1
Ahuja, S; Carter, R; Gerstein, HC; Kwan, T; Leber, B	1
Anderson, GJ; Cullen, LM; Jazwinska, EC; Powell, LW; Ramm, GA	1
Benito, A; Castro, B; Fábrega, E; Fernández-Luna, JL; Pons-Romero, F; Sánchez-Castro, L	1
Baiget, M; Barceló, MJ; Gich, I; Gimferrer, E; Nomdedeu, J	1
Marx, JJ; Swinkels, DW	1
Erhardt, A; Hassan, M; Häussinger, D; Niederau, C; Osman, Y	1
Buttenshaw, RL; Johnson, AG; Leggett, BA; Macdonald, GA; McCann, SJ; Mellick, GD; Tarish, J; Whitehall, VJ; Young, J	1
Castro, JA; Guix, P; Muncunill, J; Obrador, A; Parera, M; Picornell, A; Ramon, MM; Rossell, J; Tomás, C; Vaquer, P	1
Klingler, KR; Wielckens, K; Zech, D	1
Amarenco, P; Arveiler, D; Cambien, F; Elbaz, A; Evans, A; Gariepy, J; Grandchamp, B; Hetet, G; Kee, F; Morrison, C; Nicaud, V; Simon, A	1
Bocchi, EA; Cuoco, MA; da Silva, FF; Freitas, HF; Krieger, JE; Mansur, AJ; Mota, GF; Pereira, AC; Soler, JM	1
Hayashi, H; Ikeda, R; Imaizumi, Y; Kawanaka, M; Sanae, F; Shiono, Y; Takikawa, T; Wakusawa, S; Yamada, G; Yano, M; Yoshioka, K	1
Beckman, L; Mikelsaar, AV; Pärlist, P; Tasa, G	1
Beutler, E; Felitti, V; Gelbart, T; Ho, NJ; Waalen, J	1
Bertrand, O; Boivin, P; Galand, C	1

Reviews

6 review(s) available for tyrosine and Bronze Diabetes

Article	Year
[From gene to disease; HFE-mutations in primary haemochromatosis]. Nederlands tijdschrift voor geneeskunde, 2003, Apr-05, Volume: 147, Issue:14 Topics: Amino Acid Substitution; Cysteine; Genotype; Hemochromatosis; Hemochromatosis Protein; Histocompatibility Antigens Class I; Humans; Membrane Proteins; Mutation, Missense; Tyrosine	2003
[Iron storage disease]. Orvosi hetilap, 2004, Sep-26, Volume: 145, Issue:39 Topics: Aspartic Acid; Carcinoma, Hepatocellular; Chromosomes, Human, Pair 6; Cysteine; Diabetes Mellitus; Diagnosis, Differential; Hemochromatosis; Histidine; Humans; Hyperpigmentation; Iron Overload; Liver Cirrhosis; Liver Neoplasms; Mass Screening; Phlebotomy; Point Mutation; Population Surveillance; Prevalence; Prognosis; Tyrosine	2004
Genetic predisposition to iron overload: prevalence and phenotypic expression of hemochromatosis-associated HFE-C282Y gene mutation. Scandinavian journal of clinical and laboratory investigation, 2006, Volume: 66, Issue:2 Topics: Cysteine; Genetic Predisposition to Disease; Hemochromatosis; Hemochromatosis Protein; Histocompatibility Antigens Class I; Humans; Iron Overload; Membrane Proteins; Mutation; Prevalence; Scandinavian and Nordic Countries; Tyrosine	2006
[Liver cirrhosis associated with metabolic disorders]. Ryoikibetsu shokogun shirizu, 1995, Issue:7 Topics: alpha 1-Antitrypsin; alpha 1-Antitrypsin Deficiency; Galactosemias; Glycogen Storage Disease; Hemochromatosis; Hepatolenticular Degeneration; Humans; Liver Cirrhosis; Metabolism, Inborn Errors; Tyrosine	1995
Genetics of hemochromatosis. Annual review of medicine, 1999, Volume: 50 Topics: Amino Acid Substitution; Aspartic Acid; Cloning, Molecular; Cysteine; Genes, MHC Class I; Genes, Recessive; Hemochromatosis; Hemochromatosis Protein; Heterozygote; Histidine; Histocompatibility Antigens Class I; HLA Antigens; Homozygote; Humans; Iron; Membrane Proteins; Mutation, Missense; Tyrosine	1999
[Diagnosis and treatment of primary hemochromatosis]. Nederlands tijdschrift voor geneeskunde, 1999, Jul-03, Volume: 143, Issue:27 Topics: Cysteine; Female; Ferritins; Genetic Testing; Hemochromatosis; Homozygote; Humans; Liver Diseases; Liver Function Tests; Male; Mutation; Phlebotomy; Transferrin; Tyrosine	1999

Trials

1 trial(s) available for tyrosine and Bronze Diabetes

Article	Year
Serum iron parameters, HFE C282Y genotype, and cognitive performance in older adults: results from the FACIT study. The journals of gerontology. Series A, Biological sciences and medical sciences, 2010, Volume: 65, Issue:12 Topics: Aged; Cognition; Cross-Sectional Studies; Cysteine; Double-Blind Method; Female; Ferritins; Folic Acid; Follow-Up Studies; Genotype; Hematinics; Hemochromatosis; Humans; Iron; Male; Middle Aged; Mutation; Tunica Intima; Tunica Media; Tyrosine	2010

Article

Year

Serum iron parameters, HFE C282Y genotype, and cognitive performance in older adults: results from the FACIT study.

The journals of gerontology. Series A, Biological sciences and medical sciences, 2010, Volume: 65, Issue:12

Topics: Aged; Cognition; Cross-Sectional Studies; Cysteine; Double-Blind Method; Female; Ferritins; Folic Acid; Follow-Up Studies; Genotype; Hematinics; Hemochromatosis; Humans; Iron; Male; Middle Aged; Mutation; Tunica Intima; Tunica Media; Tyrosine

2010

Other Studies

50 other study(ies) available for tyrosine and Bronze Diabetes

Article	Year
Clinical Penetrance of Hereditary Hemochromatosis-Related End-Organ Damage of C282Y Homozygosity, A Newfoundland Experience. Clinical and translational gastroenterology, 2020, Volume: 11, Issue:11 Topics: Adult; Cysteine; Disease Progression; Female; Follow-Up Studies; Genetic Testing; Hemochromatosis; Hemochromatosis Protein; Hemosiderosis; Homozygote; Humans; Iron; Liver Cirrhosis; Male; Middle Aged; Newfoundland and Labrador; Penetrance; Retrospective Studies; Tyrosine	2020
Detection of treatable neonatal liver disease by expanded newborn screening. Journal of inherited metabolic disease, 2008, Volume: 31 Suppl 2 Topics: alpha-Fetoproteins; Amino Acid Metabolism, Inborn Errors; Antioxidants; Biomarkers; Blood Coagulation Disorders; Diagnosis, Differential; Ferritins; Hemochromatosis; Humans; Hypoalbuminemia; Infant, Newborn; Iron; Iron Chelating Agents; Liver; Male; Methionine; Neonatal Screening; Predictive Value of Tests; Tandem Mass Spectrometry; Treatment Outcome; Tyrosine	2008
Hemochromatosis protein HFE C282Y conformational considerations. Hepatology (Baltimore, Md.), 2010, Volume: 52, Issue:1 Topics: Amino Acid Substitution; Cysteine; Hemochromatosis; Hemochromatosis Protein; Histocompatibility Antigens Class I; Humans; Membrane Proteins; Mutation; Protein Conformation; Protein Folding; Protein Transport; Tyrosine	2010
Prevalence of H63D, S65C, and C282Y hereditary hemochromatosis gene variants in Madeira Island (Portugal). Annals of hematology, 2011, Volume: 90, Issue:1 Topics: Adolescent; Adult; Amino Acid Substitution; Aspartic Acid; Cysteine; Gene Frequency; Genotype; Hemochromatosis; Hemochromatosis Protein; Histidine; Histocompatibility Antigens Class I; Humans; Male; Membrane Proteins; Polymorphism, Single Nucleotide; Portugal; Prevalence; Serine; Tyrosine; Young Adult	2011
Non-alcoholic steatohepatitis (NASH) and oral lichen planus: a rare occurrence. International journal of oral and maxillofacial surgery, 2011, Volume: 40, Issue:5 Topics: Adult; Biopsy, Fine-Needle; Cysteine; Fatty Liver; Hemochromatosis; Hemochromatosis Protein; Heterozygote; Histocompatibility Antigens Class I; Humans; Lichen Planus, Oral; Male; Membrane Proteins; Mutation; Siderosis; Tyrosine	2011
Population screening for hemochromatosis: a study in 5370 Spanish blood donors. Journal of hepatology, 2003, Volume: 38, Issue:6 Topics: Adult; Aspartic Acid; Blood Donors; Cysteine; Female; Ferritins; Gene Frequency; Genetic Testing; Genotype; Hemochromatosis; Hemochromatosis Protein; Heterozygote; Histidine; Histocompatibility Antigens Class I; Homozygote; Humans; Male; Membrane Proteins; Middle Aged; Mutation; Sex Characteristics; Spain; Transferrin; Tyrosine	2003
The 16189 variant of mitochondrial DNA occurs more frequently in C282Y homozygotes with haemochromatosis than those without iron loading. Journal of medical genetics, 2004, Volume: 41, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Amino Acid Substitution; Cohort Studies; Cysteine; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; DNA, Mitochondrial; Gene Frequency; Genotype; Hemochromatosis; Hemochromatosis Protein; Histocompatibility Antigens Class I; Homozygote; Humans; Iron Overload; Membrane Proteins; Middle Aged; Mutation; Phenotype; Tyrosine	2004
Frequency of the C282Y and H63D mutations of the hemochromatosis gene (HFE) in 2501 ethnic Danes. Annals of hematology, 2004, Volume: 83, Issue:10 Topics: Aspartic Acid; Confidence Intervals; Cysteine; Denmark; Female; Gene Frequency; Genotype; Hemochromatosis; Hemochromatosis Protein; Histidine; Histocompatibility Antigens Class I; Humans; Male; Membrane Proteins; Mutation; Tyrosine	2004
HFE gene and hemochromatosis. Journal of gastroenterology and hepatology, 2004, Volume: 19, Issue:6 Topics: Aspartic Acid; Cysteine; Gene Frequency; Hemochromatosis; Hemochromatosis Protein; Heterozygote; Histidine; Histocompatibility Antigens Class I; Homozygote; Humans; Membrane Proteins; Mutation; Mutation, Missense; Tyrosine	2004
Expression of hepcidin is down-regulated in TfR2 mutant mice manifesting a phenotype of hereditary hemochromatosis. Blood, 2005, Jan-01, Volume: 105, Issue:1 Topics: Animals; Antimicrobial Cationic Peptides; Cation Transport Proteins; Cells, Cultured; Down-Regulation; Duodenum; Female; Hemochromatosis; Hepcidins; Iron; Iron-Binding Proteins; Liver; Male; Mice; Mice, Transgenic; Mutation; Phenotype; Receptors, Transferrin; RNA, Messenger; Tyrosine	2005
[Hereditary hemochromatosis: molecular diagnosis and effect of treatment]. Polskie Archiwum Medycyny Wewnetrznej, 2004, Volume: 111, Issue:5 Topics: Adult; Cysteine; Genotype; Hemochromatosis; Hemochromatosis Protein; Histocompatibility Antigens Class I; Homozygote; Humans; Male; Membrane Proteins; Mutation; Phlebotomy; Polymerase Chain Reaction; Tyrosine	2004
Impact of HFE genetic testing on clinical presentation of hereditary hemochromatosis: new epidemiological data. BMC medical genetics, 2005, Jun-01, Volume: 6 Topics: Adolescent; Adult; Aged; Amino Acid Substitution; Cohort Studies; Cysteine; Female; France; Genetic Testing; Genotype; Hemochromatosis; Hemochromatosis Protein; Histocompatibility Antigens Class I; Humans; Male; Membrane Proteins; Middle Aged; Molecular Diagnostic Techniques; Molecular Epidemiology; Sex Ratio; Tyrosine	2005
Mutations in the hemochromatosis gene (HFE) and multiple sclerosis. Neuroscience letters, 2005, Aug-05, Volume: 383, Issue:3 Topics: Adolescent; Adult; Aged; Analysis of Variance; Case-Control Studies; Cysteine; DNA Mutational Analysis; Female; Gene Frequency; Genotype; Hemochromatosis; Hemochromatosis Protein; Histocompatibility Antigens Class I; Humans; Male; Membrane Proteins; Middle Aged; Multiple Sclerosis; Mutation; Severity of Illness Index; Tyrosine	2005
Hemochromatosis gene HFE Cys282Tyr mutation analysis in a cohort of Northeast German hospitalized patients supports assumption of a North to South allele frequency gradient throughout Germany. Clinical laboratory, 2005, Volume: 51, Issue:9-10 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amino Acid Substitution; Biomarkers; Cohort Studies; Cysteine; DNA Mutational Analysis; Female; Gene Frequency; Germany; Hemochromatosis; Hemochromatosis Protein; Heterozygote; Histocompatibility Antigens Class I; Homozygote; Hospitalization; Humans; Male; Membrane Proteins; Middle Aged; Mutation; Tyrosine	2005
The C282Y mutation may have been positively selected as it mitigates the infertility of celiac disease. Medical hypotheses, 2006, Volume: 66, Issue:4 Topics: Cation Transport Proteins; Celiac Disease; Cysteine; Hemochromatosis; Humans; Infertility; Iron-Binding Proteins; Mutation; Tyrosine	2006
The effect of the metabolic syndrome, hepatic steatosis and steatohepatitis on liver fibrosis in hereditary hemochromatosis. Liver international : official journal of the International Association for the Study of the Liver, 2006, Volume: 26, Issue:3 Topics: Adult; Aged; Aspartic Acid; Cysteine; Fatty Liver; Female; Genetic Predisposition to Disease; Glucose Intolerance; Hemochromatosis; Hepatitis; Heterozygote; Histidine; Homozygote; Humans; Iron Overload; Liver Cirrhosis; Male; Metabolic Syndrome; Middle Aged; Multivariate Analysis; Predictive Value of Tests; Prospective Studies; Risk Factors; Tyrosine	2006
Spontaneous bilateral carotid artery dissection and hereditary haemochromatosis: what relationship? Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2006, Volume: 27, Issue:4 Topics: Carotid Artery, Internal, Dissection; Cysteine; Hemochromatosis; Hemochromatosis Protein; Histocompatibility Antigens Class I; Humans; Iron; Magnetic Resonance Angiography; Magnetic Resonance Imaging; Male; Membrane Proteins; Middle Aged; Mutation; Tyrosine	2006
The HLA-A1-B8 haplotype hitchhiking with the hemochromatosis mutation: does it affect the phenotype? European journal of haematology, 2007, Volume: 79, Issue:5 Topics: Adult; Aged; Cysteine; Female; Ferritins; Haplotypes; Hemochromatosis; Hemochromatosis Protein; Histocompatibility Antigens Class I; HLA-A1 Antigen; HLA-A3 Antigen; HLA-B8 Antigen; Humans; Iron Deficiencies; Male; Membrane Proteins; Middle Aged; Mutation; Pedigree; Phenotype; Sweden; Tyrosine	2007
Tauroursodeoxycholic acid: relieving the pathogenesis of HFE C282Y hereditary hemochromatosis. Hepatology (Baltimore, Md.), 2008, Volume: 48, Issue:1 Topics: Antioxidants; Cysteine; Endoplasmic Reticulum; Hemochromatosis; Hemochromatosis Protein; Histocompatibility Antigens Class I; Homozygote; Humans; Membrane Proteins; Mutation; Reactive Oxygen Species; Taurochenodeoxycholic Acid; Tyrosine	2008
Diagnosis of liver fibrosis using FibroScan and other noninvasive methods in patients with hemochromatosis: a prospective study. Gastroenterologie clinique et biologique, 2008, Volume: 32, Issue:2 Topics: Age Factors; Aspartate Aminotransferases; Biomarkers; Cohort Studies; Cysteine; Elasticity Imaging Techniques; Female; Ferritins; Follow-Up Studies; Hemochromatosis; Homozygote; Humans; Liver; Liver Cirrhosis; Male; Middle Aged; Predictive Value of Tests; Prospective Studies; Tyrosine	2008
Abnormalities of the liver and other organs. Radiologic clinics of North America, 1980, Volume: 18, Issue:2 Topics: Abnormalities, Multiple; alpha 1-Antitrypsin Deficiency; Amino Acid Metabolism, Inborn Errors; Colitis; Colon; Cystinosis; Heart Failure; Hemochromatosis; Hepatolenticular Degeneration; Humans; Liver; Liver Diseases; Necrosis; Radiography; Sclerosis; Tyrosine	1980
Mutation analysis of the HLA-H gene in Italian hemochromatosis patients. American journal of human genetics, 1997, Volume: 60, Issue:4 Topics: Chromosomes, Human, Pair 6; Cysteine; Female; Genetic Heterogeneity; Genetic Linkage; Haplotypes; Hemochromatosis; Hemochromatosis Protein; Histocompatibility Antigens Class I; HLA Antigens; Homozygote; Humans; Italy; Major Histocompatibility Complex; Male; Membrane Proteins; Mutation; Polymorphism, Single-Stranded Conformational; Sequence Analysis, DNA; Tyrosine; White People	1997
Rapid diagnosis of the HLA-H gene Cys 282 Tyr mutation in hemochromatosis by polymerase chain reaction--a very rare mutation in the Chinese population. Blood, 1997, May-01, Volume: 89, Issue:9 Topics: Base Sequence; China; Cysteine; DNA Primers; Hemochromatosis; Hemochromatosis Protein; Histocompatibility Antigens Class I; HLA Antigens; Humans; Major Histocompatibility Complex; Membrane Proteins; Point Mutation; Polymerase Chain Reaction; Tyrosine	1997
Genetic and clinical description of hemochromatosis probands and heterozygotes: evidence that multiple genes linked to the major histocompatibility complex are responsible for hemochromatosis. Blood cells, molecules & diseases, 1997, Volume: 23, Issue:1 Topics: Adult; Alleles; Aspartic Acid; Chromosomes, Human, Pair 6; Cysteine; Female; Gene Frequency; Genes, MHC Class I; Genetic Linkage; Hemochromatosis; Heterozygote; Histidine; Histocompatibility Testing; HLA Antigens; Homozygote; Humans; Iron; Male; Middle Aged; Mutation; Tyrosine; White People	1997
Homozygosity for the predominant Cys282Tyr mutation and absence of disease expression in hereditary haemochromatosis. Journal of medical genetics, 1997, Volume: 34, Issue:9 Topics: Adult; Age of Onset; Aged; Aged, 80 and over; Cysteine; Female; Hemochromatosis; Hemochromatosis Protein; Histocompatibility Antigens Class I; HLA Antigens; Homozygote; Humans; Iron; Liver; Male; Membrane Proteins; Middle Aged; Mutation; Pedigree; Transferrin; Tyrosine	1997
Rapid diagnosis of asymptomatic hereditary haemochromatosis by detection of the Cys282Tyr mutation in the HLA-H gene. Postgraduate medical journal, 1997, Volume: 73, Issue:863 Topics: Cysteine; DNA Mutational Analysis; Female; Genes, MHC Class I; Hemochromatosis; Humans; Middle Aged; Mutation; Polymerase Chain Reaction; Tyrosine	1997
Molecular analysis of HLA-H gene mutations in New Zealand patients with haemochromatosis. The New Zealand medical journal, 1997, Nov-28, Volume: 110, Issue:1056 Topics: Adult; Aged; Aged, 80 and over; Amino Acid Substitution; Cysteine; DNA Mutational Analysis; Female; Gene Frequency; Hemochromatosis; Hemochromatosis Protein; Histocompatibility Antigens Class I; HLA Antigens; Homozygote; Humans; Male; Membrane Proteins; Middle Aged; Mutation; New Zealand; Polymerase Chain Reaction; Restriction Mapping; Tyrosine	1997
Thrombotic thrombocytopenic purpura in a patient with genetic haemochromatosis, liver cirrhosis and an iron-free focus. British journal of haematology, 1997, Volume: 99, Issue:4 Topics: Adult; Cytosine; Hemochromatosis; Humans; Liver Cirrhosis; Male; Mutation; Purpura, Thrombotic Thrombocytopenic; Tyrosine	1997
A PCR-SSP method for detecting the Cys282Tyr mutation in the HFE gene associated with hereditary haemochromatosis. Molecular pathology : MP, 1997, Volume: 50, Issue:5 Topics: Cysteine; DNA Primers; Hemochromatosis; Humans; Molecular Sequence Data; Point Mutation; Polymerase Chain Reaction; Tyrosine	1997
HFE codon 63/282 (H63D/C282Y) dimorphism in German patients with genetic hemochromatosis. Tissue antigens, 1998, Volume: 51, Issue:3 Topics: Aspartic Acid; Codon; Cysteine; Female; Genotype; Germany; Hemochromatosis; Hemochromatosis Protein; Histidine; Histocompatibility Antigens Class I; HLA Antigens; Humans; Male; Membrane Proteins; Point Mutation; Polymorphism, Genetic; Tyrosine	1998
Rapid diagnostic test for detection of Cys282Tyr mutation in hereditary hemochromatosis. Digestive diseases and sciences, 1998, Volume: 43, Issue:6 Topics: Cysteine; DNA Primers; Hemochromatosis; Histocompatibility Antigens Class I; HLA Antigens; Humans; Mutation; Polymerase Chain Reaction; Tyrosine	1998
C282Y mutation in HFE (haemochromatosis) gene and type 2 diabetes. Lancet (London, England), 1998, Jun-27, Volume: 351, Issue:9120 Topics: Adult; Codon; Cysteine; Diabetes Mellitus, Type 2; England; Female; Genetic Predisposition to Disease; Genetic Testing; Hemochromatosis; Humans; Male; Middle Aged; Mutation; Polymerase Chain Reaction; Prevalence; Tyrosine	1998
Mutations in HFE, the hemochromatosis candidate gene, in patients with NIDDM. Diabetes care, 1998, Volume: 21, Issue:8 Topics: Amino Acid Substitution; Aspartic Acid; Cysteine; Diabetes Mellitus, Type 2; Hemochromatosis; Hemochromatosis Protein; Histidine; Histocompatibility Antigens Class I; HLA Antigens; Homozygote; Humans; Major Histocompatibility Complex; Membrane Proteins; Point Mutation; Reference Values; Tyrosine	1998
Frequency of the HFE C282Y and H63D mutations in distinct ethnic groups living in Spain. Journal of medical genetics, 1998, Volume: 35, Issue:8 Topics: Alleles; Aspartic Acid; Cysteine; Ethnicity; Genotype; Hemochromatosis; Hemochromatosis Protein; Histidine; Histocompatibility Antigens Class I; HLA Antigens; Humans; Membrane Proteins; Mutation; Roma; Spain; Tyrosine	1998
Non-C282Y familial iron overload: evidence for locus heterogeneity in haemochromatosis. Journal of medical genetics, 1998, Volume: 35, Issue:11 Topics: Adult; Amino Acid Substitution; Cysteine; Female; Genetic Diseases, Inborn; Genetic Heterogeneity; Hemochromatosis; Humans; Iron Overload; Male; Middle Aged; Tyrosine	1998
Celtic origin of the C282Y mutation of hemochromatosis. Blood cells, molecules & diseases, 1998, Volume: 24, Issue:4 Topics: Europe; Gene Frequency; Genes, MHC Class I; Hemochromatosis; Hemochromatosis Protein; Histocompatibility Antigens Class I; HLA Antigens; Humans; Membrane Proteins; Mutation; Tyrosine	1998
High incidence of the Cys 282 Tyr mutation in the HFE gene in the Irish population--implications for haemochromatosis. Tissue antigens, 1998, Volume: 52, Issue:5 Topics: Cysteine; Genes, MHC Class I; Hemochromatosis; Hemochromatosis Protein; Histocompatibility Antigens Class I; HLA Antigens; Humans; Incidence; Ireland; Membrane Proteins; Point Mutation; Tyrosine	1998
Patients with type 2 diabetes have a high frequency of the C282Y mutation of the hemochromatosis gene. Clinical and investigative medicine. Medecine clinique et experimentale, 1998, Volume: 21, Issue:6 Topics: Adolescent; Adult; Cysteine; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Hemochromatosis; Humans; Male; Middle Aged; Point Mutation; Tyrosine	1998
[The prevalence of the Cys282Tyr mutation in the hemochromatosis gene in Cantabria in patients diagnosed with hereditary hemochromatosis]. Medicina clinica, 1999, Apr-10, Volume: 112, Issue:12 Topics: Base Sequence; Cysteine; DNA Primers; Female; Gene Frequency; Genotype; Hemochromatosis; Humans; Male; Molecular Sequence Data; Mutation; Phenotype; Polymerase Chain Reaction; Prevalence; Spain; Tyrosine	1999
Prevalence of hemochromatosis related HFE gene mutations in patients with acute myeloid leukemia. Leukemia research, 1999, Volume: 23, Issue:6 Topics: Acute Disease; Codon; Cysteine; Hemochromatosis; Humans; Leukemia, Myeloid; Mutation; Prevalence; Tyrosine	1999
[Demonstration of HFE polymorphism in German patients with hereditary hemochromatosis]. Deutsche medizinische Wochenschrift (1946), 1999, Dec-03, Volume: 124, Issue:48 Topics: Amino Acid Sequence; Asparagine; Chromosomes, Human, Pair 6; Codon; Cysteine; Germany; Hemochromatosis; Heterozygote; Histidine; HLA Antigens; Homozygote; Humans; Molecular Sequence Data; Point Mutation; Polymerase Chain Reaction; Polymorphism, Genetic; Tyrosine	1999
No evidence of increased risk of colorectal cancer in individuals heterozygous for the Cys282Tyr haemochromatosis mutation. Journal of gastroenterology and hepatology, 1999, Volume: 14, Issue:12 Topics: Aged; Chi-Square Distribution; Colorectal Neoplasms; Cysteine; Electrophoresis, Polyacrylamide Gel; Female; Genes, MHC Class I; Hemochromatosis; Hemochromatosis Protein; Heterozygote; Histocompatibility Antigens Class I; HLA Antigens; Humans; Male; Membrane Proteins; Mutation; Polymerase Chain Reaction; Risk Factors; Tyrosine	1999
Prevalence of the C282Y mutation for haemochromatosis on the Island of Majorca. Clinical genetics, 2000, Volume: 58, Issue:2 Topics: Adult; Cysteine; DNA Primers; Female; Hemochromatosis; Hemochromatosis Protein; Heterozygote; Histocompatibility Antigens Class I; HLA Antigens; Homozygote; Humans; Male; Membrane Proteins; Mutation; Polymerase Chain Reaction; Prevalence; Seroepidemiologic Studies; Spain; Tyrosine	2000
Haemochromatosis: automated detection of the two point mutations in the HFE gene: Cys282Tyr and His63Asp. Clinical chemistry and laboratory medicine, 2000, Volume: 38, Issue:12 Topics: Aspartic Acid; Cysteine; DNA Mutational Analysis; Hemochromatosis; Hemochromatosis Protein; Heterozygote; Histidine; Histocompatibility Antigens Class I; HLA Antigens; Humans; Membrane Proteins; Mutation; Point Mutation; Polymerase Chain Reaction; Reproducibility of Results; Sensitivity and Specificity; Tyrosine	2000
Association studies between haemochromatosis gene mutations and the risk of cardiovascular diseases. European journal of clinical investigation, 2001, Volume: 31, Issue:5 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Arteriosclerosis; Aspartic Acid; Brain Infarction; Cardiovascular Diseases; Case-Control Studies; Cysteine; Female; France; Genetic Predisposition to Disease; Genotype; Hemochromatosis; Hemochromatosis Protein; Histidine; Histocompatibility Antigens Class I; HLA Antigens; Humans; Male; Membrane Proteins; Middle Aged; Mutation; Myocardial Infarction; Northern Ireland; Polymorphism, Genetic; Prevalence; Prospective Studies; Tyrosine; Ultrasonography; United Kingdom	2001
Hemochromatosis gene variants in patients with cardiomyopathy. The American journal of cardiology, 2001, Aug-15, Volume: 88, Issue:4 Topics: Adolescent; Adult; Aged; Aspartic Acid; Cardiomyopathies; Cysteine; Disease Progression; Female; Genotype; Heart Failure; Hemochromatosis; Histidine; Humans; Logistic Models; Male; Middle Aged; Mutation, Missense; Prognosis; Tyrosine	2001
C282Y and H63D mutations in the HFE gene have no effect on iron overload disorders in Japan. Internal medicine (Tokyo, Japan), 2001, Volume: 40, Issue:9 Topics: Adult; Asian People; Aspartic Acid; Cysteine; Female; Hemochromatosis; Hemochromatosis Protein; Hepatitis C, Chronic; Histidine; Histocompatibility Antigens Class I; HLA Antigens; Humans; Iron Overload; Japan; Liver Diseases; Male; Membrane Proteins; Middle Aged; Point Mutation; Polymerase Chain Reaction; Tyrosine	2001
The frequency of C282Y and H63D mutations in Hemochromatosis gene in native Estonians. European journal of epidemiology, 2001, Volume: 17, Issue:3 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alleles; Aspartic Acid; Cysteine; DNA Mutational Analysis; DNA Primers; Estonia; Female; Gene Frequency; Genotype; Hemochromatosis; Histidine; Humans; Male; Middle Aged; Mutation; Polymerase Chain Reaction; Tyrosine	2001
Prevalence of hemochromatosis-related symptoms among individuals with mutations in the HFE gene. Mayo Clinic proceedings, 2002, Volume: 77, Issue:6 Topics: Adult; Aged; Aspartic Acid; Case-Control Studies; Cysteine; Double-Blind Method; Female; Ferritins; Genetic Predisposition to Disease; Genetic Testing; Genotype; Hemochromatosis; Hispanic or Latino; Histidine; Homozygote; Humans; Male; Middle Aged; Mutation; Prevalence; Surveys and Questionnaires; Transferrin; Tyrosine; United States; White People	2002
Protein band 3 phosphotyrosyl phosphatase. Purification and characterization. The International journal of biochemistry, 1987, Volume: 19, Issue:7 Topics: Anion Exchange Protein 1, Erythrocyte; Erythrocytes; Hemochromatosis; Humans; Kinetics; Molecular Weight; Phosphoprotein Phosphatases; Protein Tyrosine Phosphatases; Tyrosine	1987